Amphastar Pharmaceuticals Inc. Registered Shares DL -,0001
- BID
17.225
- ASK
17.275
- 581 Units579 Units
- 07/21, 19:02:55 PM
Sector and Industry
Healthcare, Biopharmaceuticals
Performance (1Y)
2.36%
Market Cap
-
P/E Ratio
13.16
Dividend Yield
0.00 %
Earnings per Share
1.80 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Eli Lilly and Company | 864.54 Bil. | 57.78 Bil. | 46.82 | +86.88 % | 0.00 | - |
| Johnson & Johnson | 425.70 Bil. | 83.48 Bil. | 18.82 | +82.71 % | 0.00 | - |
| AbbVie Inc. | 343.94 Bil. | 54.21 Bil. | 96.78 | -5.29 % | 0.00 | - |
| Roche Holding AG | 286.62 Bil. | 65.80 Bil. | 20.72 | +58.45 % | 0.00 | - |
| AstraZeneca PLC | 244.91 Bil. | 52.09 Bil. | 27.55 | +39.41 % | 0.00 | - |
| NOVARTIS AG | 224.76 Bil. | 48.44 Bil. | 18.30 | +12.45 % | 0.00 | - |
| Merck & Co. Inc. | 221.79 Bil. | 57.55 Bil. | 14.46 | +2.25 % | 0.00 | - |
| Novo-Nordisk AS B | 193.52 Bil. | 41.49 Bil. | 14.11 | +1.54 % | 0.00 | - |
| Amgen Inc. | 150.16 Bil. | 32.57 Bil. | 23.01 | +80.77 % | 0.00 | - |
| Gilead Sciences Inc. | 129.70 Bil. | 26.10 Bil. | 18.10 | +1,599.93 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 17.205 G | 0 Units |
| PRICE DETERMINATION TIME | 07/21/2026 / 07:02:16 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 17.32 | 16.85 |
| PREV. DAY'S PRICE | 17.195 | (07/20) |
| CHANGE DAY BEFORE | +0.01 | 0.06 % |
| 52 WEEK HIGH / LOW | 26.19 (09/02) | 14.205 (05/18) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | 2.40 | 2.83 | 1.80 | 2.30 | 2.78 |
DIVIDENDS PER SHARE | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
DIVIDEND YIELD IN % | 0.00 % | 0.00 % | 0.00 % | - | - |
DIVIDEND GROWTH IN % | - | - | - | - | - |
PRICE - EARNINGS RATIO | 23.83 | 12.12 | 13.16 | 7.51 | 6.21 |
PRICE - BOOK RATIO | 4.65 | 2.41 | 1.55 | - | - |
PRICE - SALES RATIO | 5.09 | 2.64 | 1.79 | - | - |
PRICE - CASH FLOW RATIO | 17.86 | 9.06 | 8.27 | - | - |
Master Data
| WKN | A11664 |
| ISIN | US03209R1032 |
| SYMBOL | 29A |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | AMPHASTAR PHARMA.DL-,0001 |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | - |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Biopharmaceuticals |
| NUMBER OF SHARES | - |
| MARKET CAPITALISATION | - |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 1.42 % | 6.44 % | -11.59 % | -21.98 % | -2.36 % | -68.16 % | 2.35 % | -22.51 % |
| HIGH | 17.55 | 19.00 | 20.50 | 24.85 | 26.19 | 58.00 | 58.00 | 25.08 |
| LOW | 16.09 | 15.75 | 14.21 | 14.21 | 14.21 | 14.21 | 14.21 | 14.21 |
Dividende
pro Aktie
AMPHASTAR PHARMA.DL-,0001 does not deliver dividend information
Company profile
Amphastar Pharmaceuticals, Inc. engages in developing, manufacturing, and commercializing technically challenging generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredients. It operates through Pharmaceutical Products segment. The company was founded by Zi-Ping Luo and Yong Feng Zhang on February 29, 1996 and is headquartered in Rancho Cucamonga, CA.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.